Needham & Company LLC reaffirmed their buy rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a report published on Tuesday,Benzinga reports. Needham & Company LLC currently has a $4.00 target price on the stock.
A number of other research analysts also recently issued reports on the company. Stifel Nicolaus dropped their price target on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and reduced their price target for the company from $5.00 to $2.85 in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, DocGo has an average rating of “Moderate Buy” and a consensus target price of $4.89.
Check Out Our Latest Stock Report on DocGo
DocGo Stock Performance
Institutional Trading of DocGo
Several hedge funds have recently made changes to their positions in the company. WCM Investment Management LLC boosted its holdings in DocGo by 64.2% in the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares in the last quarter. American Century Companies Inc. increased its stake in DocGo by 490.3% in the 4th quarter. American Century Companies Inc. now owns 452,254 shares of the company’s stock valued at $1,918,000 after purchasing an additional 375,637 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock valued at $5,647,000 after purchasing an additional 363,391 shares during the last quarter. Northern Trust Corp increased its position in shares of DocGo by 24.9% in the fourth quarter. Northern Trust Corp now owns 1,606,139 shares of the company’s stock valued at $6,810,000 after buying an additional 320,133 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in DocGo by 583.4% in the 4th quarter. Renaissance Technologies LLC now owns 350,600 shares of the company’s stock valued at $1,487,000 after acquiring an additional 299,300 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
- Five stocks we like better than DocGo
- Investing In Preferred Stock vs. Common Stock
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- The How And Why of Investing in Oil Stocks
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.